ProMIS Neurosciences (PMN) Debt Ratio (2021)
ProMIS Neurosciences' (PMN) quarterly Debt Ratio came in at 0.22 in Q4 2021.
ProMIS Neurosciences (PMN) Debt Ratio (2021) Analysis & Trends
ProMIS Neurosciences (PMN) has 1 years of Debt Ratio data on file, last reported at 0.22 in Q4 2021.
- Quarterly Debt Ratio changed N/A year-over-year to 0.22 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was 0.22 (changed N/A YoY) and the FY2021 annual result came in at 0.22, changed N/A from the prior year.
- Debt Ratio was little changed at 0.22 in Q4 2021.
- In the past five years, Debt Ratio ranged from a high of 0.22 in Q4 2021 to a low of 0.22 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 0.47 |
| 10 | ProMIS Neurosciences | 135.63 Mn | 82.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 0.22 |